OXiGENE Soaring, Up 45% (OXGN)

OXiGENE, Inc. OXGN shares are soaring today, gaining 45% on more than ten times its average daily volume. At last check shares of OXiGene were up $1.10 to $3.45, a gain of 46% on 5.5 million shares. OXiGENE, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat cancer and eye diseases in the United States.